ROXIF saw its Momentum Indicator move above the 0 level on December 11, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 67 similar instances where the indicator turned positive. In of the 67 cases, the stock moved higher in the following days. The odds of a move higher are at .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ROXIF's RSI Indicator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ROXIF just turned positive on December 11, 2024. Looking at past instances where ROXIF's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for ROXIF moved below the 200-day moving average on December 06, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Aroon Indicator for ROXIF entered a downward trend on December 18, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.969) is normal, around the industry mean (4.423). P/E Ratio (18.149) is within average values for comparable stocks, (19.470). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.566). Dividend Yield (0.027) settles around the average of (0.084) among similar stocks. P/S Ratio (4.144) is also within normal values, averaging (156.728).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ROXIF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ROXIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
Industry OilGasProduction
A.I.dvisor tells us that ROXIF and RECAF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ROXIF and RECAF's prices will move in lockstep.
Ticker / NAME | Correlation To ROXIF | 1D Price Change % | ||
---|---|---|---|---|
ROXIF | 100% | N/A | ||
RECAF - ROXIF | 31% Poorly correlated | +2.21% | ||
PTRUF - ROXIF | 3% Poorly correlated | +1.69% | ||
PTVRF - ROXIF | 3% Poorly correlated | N/A | ||
QTEYF - ROXIF | 0% Poorly correlated | N/A | ||
PXPEF - ROXIF | 0% Poorly correlated | N/A | ||
More |